API Contract Manufacturing Market is worth USD 66.54 billion in 2016 and is expected to reach USD 103.40 billion by 2022, growing at a CAGR of 7.6% from 2016 to 2022.

The objective of this report is to describe the market trends and revenue forecasts for the api contract manufacturing market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the api contract manufacturing market. The scope of this report covers the api contract manufacturing market by its major segments, which include the type, synthesis, drug type, therapeutic area, and the major geographic regions.

KEY BENEFITS OF THE REPORT:
In-depth analysis of the key factors are propelling the growth of the global market
Detailed analysis of the geographic region that will witness the strongest growth
Granular analysis of the current market scenario and the expected market grow
KEY PREMIUM INDUSTRY INSIGHTS:
The availability of inexpensive labor in the emerging markets, the easily available resources, and the easy access to the advanced technologies are some of the major driving factors for the API contract manufacturing market, during the forecast period.
The factors such as the increasing need to focus on the core activities and to hasten the drug development processes will provide significant growth opportunities for the API contract manufacturing market in the near future.
Apart from that, a considerable reduction in the time-to-market process will further provide some major growth opportunities for the growth of this market.
MARKET SEGMENTATION:
This report analyzes the API contract manufacturing market by the following segments:

API Contract Manufacturing Market, by Synthesis
Synthetic
Biological
API Contract Manufacturing Market, by Drug Type
Generic
Branded
API Contract Manufacturing Market, by Therapeutic Area
Cardiovascular Disorders
Metabolic Disorders
CNS
Oncology
Musculoskeletal Diseases
NSAIDs
Others
KEY MARKET PLAYERS:
Key players in the API contract manufacturing market include:

Teva Pharmaceutical Industries, Ltd.
Sun Pharmaceutical Industries, Ltd.
Dr.Reddy's Laboratories
Aurobindo Pharma Ltd.
Mylan N.V.
Novartis AG
Cambrex Corporation
Boehringer Ingelheim GmbH
Pfizer, Inc.
Lonza Group